Download as pdf or txt
Download as pdf or txt
You are on page 1of 1

This site is intended for healthcare professionals

SECTIONS

Drugs & Diseases > Gastroenterology

Crohn
Disease Differential
Diagnoses
Updated: Jul 26, 2019 | Author: Leyla J Ghazi, MD; Chief
Editor: Praveen K Roy, MD, AGAF more...

Share

Diagnostic Considerations
Patients with Crohn disease frequently present with
abdominal pain, nonbloody diarrhea, weight loss,
fever, and, sometimes, obstructive symptoms such as
nausea, early satiety, and vomiting. World Health
Organization diagnostic criteria for Crohn disease
include the following [57] :

Discontinuous or segmental lesions as well as a


cobblestone appearance or longitudinal
ulcer noted on radiologic studies, endoscopy,
and resected specimens
Transmural inflammation, as evidenced by
clinical evaluation, radiologic studies, biopsy
findings, and resected specimens
Noncaseating granulomas, as revealed on
biopsy findings and resected specimens
Fissures and fistulas, as evidenced by clinical
evaluation, radiologic studies, and resected
specimens
Perianal disorders on clinical evaluation

A variety of intestinal manifestations and


extraintestinal manifestations (EIMs) also may be
observed in conjunction with either Crohn disease or
ulcerative colitis. Features differentiating the two
forms of inflammatory bowel disease (IBD) are
summarized in Table 1, below.

Table 1. Characteristics Differentiating Crohn Disease


and Ulcerative Colitis (Open Table in a new window)

Characteristic

Ulcerative
Crohn Disease
Colitis

Entire Colon only,


gastrointestinal though gastritis
tract is recognized

Distribution
Continuous
involvement
Skip lesions
proximally from
rectum

Full thickness Mucosa only

Granulomas (15-
Pathology
30% in biopsy
specimens; 40- No granulomas
60% in surgically
resected bowel)

Entire
gastrointestinal Colon only
tract

Continuous
involvement
Radiology Skip lesions
proximally from
rectum

Fistulae,
Mucosal
abscesses,
disease only
fibrotic strictures

Estimated to
be 3% at 10
years, 8% at 30
years, and 18%
at 30 years
after diagnosis
[47] ; risk is
higher in
patients with
Cancer risk Increased primary
sclerosing
cholangitis and
long-standing
colitis (> 8-10 y);
may be lower
in subsequent
studies (see
Intestinal
Manifestations).

Presentation

Ulcerative
Crohn Disease
Colitis

Bleeding Occasional Very common

Obstruction Common Uncommon

Fistulae Common None

Weight loss Common Uncommon

Perianal
Common Rare
disease

Other diagnostic considerations


Despite extensive workup, 15% of patients with
isolated colitis have an undetermined type of IBD
that shows features of both Crohn disease and
ulcerative colitis. The distinction is often difficult to
make, especially if the patient meets all diagnostic
criteria for ulcerative colitis but is a smoker or has
rectal sparing—features that suggest the possibility
of Crohn disease or IBD of undetermined type.

In addition, there is a subpopulation of patients with


Crohn colitis who will not develop small bowel
disease in their lifetime. This group represents
approximately 20% of the colitis patients.

Tuberculosis is also in the differential diagnosis of


Crohn disease. Simple clinical findings (eg, fever,
rectal bleeding, diarrhea, symptomatic duration)
appear to be most accurate for differentiating Crohn
disease from intestinal tuberculosis. [57]
Anti–Saccharomyces cerevisiae antibodies (ASCA)
do not help in differentiating small bowel
tuberculosis from small bowel Crohn disease, but if
both ASCA and interferon-gamma release assays are
available and the ASCA result is positive, while the
interferon gamma release assay result is negative,
the specificity for Crohn disease is high, particularly
in Asian populations. [57] Endoscopy in combination
with radiologic and laboratory findings are also
useful for differentiating between Crohn disease and
intestinal tuberculosis.

In addition to excluding ulcerative colitis and


intestinal tuberculosis, guidelines from the World
Gastroenterology Organization recommend ruling
out the following in the differential diagnoses of
Crohn disease [58, 57] :

Behςet disease

Celiac disease

Irritable bowel syndrome (IBS) (if inflammatory


changes are present, it is not IBS)

Nonsteroidal anti-inflammatory drug (NSAID)


enteropathy

Differential Diagnoses
Amebiasis

Appendicitis

Bacterial Gastroenteritis

Behcet Disease

Celiac Disease and HLA-DQ2/DQ8

Diverticulitis

Giardiasis

Intestinal Carcinoid Tumor

Intestinal Tuberculosis

Irritable Bowel Syndrome (IBS)

Ischemia

Tuberculosis

Ulcerative Colitis

Viral Gastroenteritis

Workup

SECTIONS
Crohn Disease

Overview

Presentation

DDx

Workup

Treatment

Guidelines

Medication

Questions & Answers

Media Gallery

Tables

References

What to Read Next on


Medscape

Related Conditions and Diseases


Crohn Disease Pathology

Crohn Disease and NOD2/CARD15

Pediatric Crohn Disease Surgery

Pediatric Crohn Disease

Crohn Disease Imaging

Fast Five Quiz: Test Yourself on Crohn


Disease

NEWS & PERSPECTIVE

SEAVUE: Ustekinumab vs
Adalimumab for Crohn's Disease
Compared in Head-to-Head Trial

VENUS: Ustekinumab Appears Superior to


Vedolizumab for Refractory Crohn's
Disease

IBD-Related Colon Dysplasia Less


Prevalent in Hispanic vs Non-Hispanic
White Patients

TOOLS

Drug Interaction Checker

Pill Identifier

Calculators

Formulary

SLIDESHOW

Medicine as Art: The Best in


Medical and Science Imagery

Most Popular Articles


According to Gastroenterologists

1. How to Become an 'Ink Master':


Endoscopic Colonic Tattooing Tips

2. High Rates of Sustained


Virological Response Despite
Premature Discontinuation of
Directly Acting Antivirals in HCV-
infected Patients Treated in a
Real-life Setting

3. Patients With Decompensated


Cirrhosis Often Lack Advance
Care Plans

4. The Gut Microbiota in


Osteoarthritis

5. Olamkicept May Induce Response


in IBD Patients

View More

FIND US ON

ABOUT
About Medscape

Privacy Policy

Editorial Policy

Cookies

Terms of Use

Advertising Policy

Help Center

MEMBERSHIP
About You

Professional Information

Newsletters & Alerts

APPS
Medscape

CME & Education

WEBMD NETWORK
Medscape Live Events

WebMD

MedicineNet

eMedicineHealth

RxList

WebMD Corporate

EDITIONS
English

Deutsch

Español

Français

Português

All material on this website is protected by copyright, Copyright ©


1994-2021 by WebMD LLC. This website also contains material
copyrighted by 3rd parties.

You might also like